We found significant associations for CRP with NASH (OR, 1.60; 95% CI, 1.17‐2.19; P=0.003) and hepatic fibrosis (OR, 1.18; 95% CI, 1.06‐1.32; P=0.003), which were consistent with overall effect (Figure 2B). Here, CRP is linked to metabolic dysfunction-associated steatohepatitis.